Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 801 results for "pfizer drugmaker pfizer"

GSK share price steady as pharmco divests two meningitis vaccines

GSK to Sell Two Meningitis Vaccines to Pfizer

GlaxoSmithKline (GSK) has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis. The British drugmaker said that the total consideration for the sale of its ... PharmaAsia, 1 week ago

31 images for pfizer drugmaker pfizer

Washington Post, 3 weeks ago, 1 month ago
Oman Observer, 2 months ago
Jutia Group, 2 months ago
Business Insider, 2 months ago
Malay Mail, 2 months ago, 2 months ago
Reuters UK, 2 months ago
Channel NewsAsia, 2 months ago, 2 months ago

Pfizer buying vaccines from GSK for $130mn

NEW YORK: Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the US drugmaker valued at about $130 million. GlaxoSmithKline PLC was required to sell the vaccines, called Nimenrix and Mencevax, as part of a larger deal where it bought ...
 Economic Times1 week ago Pfizer to buy two vaccines from Glaxo  NineMSN Finance1 week ago Pfizer buying 2 meningitis vaccines from Glaxo for $130M  Miami Herald1 week ago Pfizer to pay $130 million for two meningitis vaccines from GlaxoSmithKline  Financial Content1 week ago

Pfizer Spinoff Zoetis Chops 165 HQ Jobs as Part of Global Restructuring

June 15, 2015 By Mark Terry , Breaking News Staff Zoetis ( GZTS ), a spinoff of Pfizer Inc. ( PFE ), filed a WARN notice with the State of New Jersey last week indicating it planned to cut about 165 jobs by Dec. 31, 2016. ...
 BioSpace2 weeks ago Jury says Pfizer did not fail to warn about Zoloft birth-defect links  UnitedHealthcare2 weeks ago Pfizer Inc. Wards Off Another Birth Defect Case Against Antidepressant Zoloft  Bidness Etc2 weeks ago Zoloft warnings were sufficient, jury decides in trial against drugmaker  Washington Post3 weeks ago
International Business Times UK

French biotech firm Cellectis jumps 10% on reported interest from Pfizer

Shares in French cancer drugmaker Cellectis struck an all-time high on 29 May on hopes that it will be the latest in a string of bid targets in the healthcare industry. Shares in Cellectis were trading 10.23% higher at 03.15pm in Paris, after ...
 International Business Times UK1 month ago French drugmaker Cellectis' shares all time high after Pfizer shows bid interests  Economic Times1 month ago Pfizer in talks to acquire Cellectis: report  FirstWord Pharma1 month ago

Is Pfizer On The Brink Of A New Mega-Deal?

Pfizer is looking again for significant acquisitions, whilst in the process of buying Hospira, with analysts suggesting that GlaxoSmithKline, Perrigo, Shire and AstraZeneca are among the companies in Pfizer's wish-list of targets, Forbes reported ...
 FirstWord Pharma1 month ago Investors eye Pfizer mega-deal  IOL1 month ago Investors eyes Pfizer mega-deal  IOL1 month ago

Pfizer MD set for a global role with parent company

Drugmaker Pfizer's Managing Director Aijaz Jazz Tobaccowalla, who has overseen mergers and more in the Indian market, is set to step into a new global role with the US parent company. Though Tobaccowalla has been offered a new global role that he ...
 Hindu Business Line3 weeks ago
Motley Fool

Pfizer's Monstrous Clinical Pipeline Is Harboring 2 Hidden Gems

Its jaw-dropping size can nevertheless act as a major impediment for investors trying to get a handle on the drugmaker's forward-looking prospects. A recent clinical update, for instance, revealed that Pfizer has a staggering 88 ongoing clinical ...
 Motley Fool1 month ago

French drugmaker Cellectis in sale talks -FT

French cancer drugmaker Cellectis is in potential sale talks with a few suitors, including U.S. based Pfizer Inc, the Financial Times reported citing people familiar with the matter. Although no
 Yahoo! UK and Ireland1 month ago Rumored Pfizer Deal To Buy Cellectis for $1.64 Billion Could Lock in CRISPR and CAR T Tech  BioSpace1 month ago

All Eyes on Pfizer as Shareholders Await the Mega-Deal

Pfizer Inc. built itself into a $212 billion behemoth by spending more money on acquisitions than any other drugmaker in the world. Still, Pfizer's next purchase is what will really leave its mark as a dealmaker. The company may be plotting its ...
 Bloomberg1 month ago

AstraZeneca looks beyond Nexium hit with new cancer deals

The drugmaker, which saw off a $118 billion bid by Pfizer last year, said its sales fell by a slightly less-than-expected 6% in the first quarter. LONDON: AstraZeneca has sharpened its focus on cancer drugs with two new deals as it looks beyond a hit to sales ...
 Economic Times2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less